Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Respiratory Drive in ARDS
NCT05514483Phase 4Unknown
- Start
- Nov 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ondansetron in acute respiratory distress syndrome (ARDS). Primary endpoint: Pressure-time product of the esophageal pressure per minute at 2 hours. Status: unknown.
02
Drugs
ondansetron
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05514483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514483.